Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease
- PMID: 17055329
- DOI: 10.1016/j.parkreldis.2006.06.012
Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease
Abstract
The study purpose was to assess the efficacy of intermittent subcutaneous apomorphine (APO) as acute therapy for off episodes in advanced Parkinson's disease (PD) patients who had previously received APO for 3 months. Patients (n=62) were randomized to receive double-blind treatment with APO at their typically effective dose (TED; APO), APO at their TED+0.2mL (2.0mg; APO+2), placebo at volume equal to their TED (PL), or placebo at volume equal to their TED+0.2mL (PL+2), for a single off episode. Significantly greater improvement in mean Unified PD rating scale motor scores was seen with pooled APO versus pooled placebo 20min after administration (-24.2 vs. -7.4; p<0.0001); the difference was also significant at 10min (p<0.0001). Overall adverse event incidence did not significantly differ between pooled APO and pooled PL. This study supports the long-term use of intermittent APO as effective acute therapy for off episodes in advanced PD patients.
Comment in
-
Recurrent atrial fibrillation after subcutaneous apomorphine.Parkinsonism Relat Disord. 2008;14(2):173-4; author reply 175. doi: 10.1016/j.parkreldis.2007.05.012. Epub 2007 Jul 13. Parkinsonism Relat Disord. 2008. PMID: 17632031 No abstract available.
Similar articles
-
Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose.J Neurol Sci. 2007 Jul 15;258(1-2):137-43. doi: 10.1016/j.jns.2007.03.013. Epub 2007 Apr 27. J Neurol Sci. 2007. PMID: 17466338 Clinical Trial.
-
A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.Clin Ther. 2005 Nov;27(11):1710-24. doi: 10.1016/j.clinthera.2005.11.016. Clin Ther. 2005. PMID: 16368444 Review.
-
Apomorphine for the acute treatment of "off" episodes in Parkinson's disease.Parkinsonism Relat Disord. 2008;14(2):85-92. doi: 10.1016/j.parkreldis.2007.07.016. Epub 2007 Dec 21. Parkinsonism Relat Disord. 2008. PMID: 18083605 Review.
-
Open-label study assessment of safety and adverse effects of subcutaneous apomorphine injections in treating "off" episodes in advanced Parkinson disease.Clin Neuropharmacol. 2009 Mar-Apr;32(2):89-93. doi: 10.1097/WNF.0B013E31816D91F9. Clin Neuropharmacol. 2009. PMID: 18978491 Clinical Trial.
-
Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.Mov Disord. 2010 Feb 15;25(3):368-76. doi: 10.1002/mds.22922. Mov Disord. 2010. PMID: 20063435 Clinical Trial.
Cited by
-
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson's disease: the APOKADO study.J Neural Transm (Vienna). 2023 Nov;130(11):1463-1474. doi: 10.1007/s00702-023-02609-6. Epub 2023 Mar 2. J Neural Transm (Vienna). 2023. PMID: 36862190 Free PMC article.
-
Intermittent subcutaneous apomorphine therapy for 'off' episodes in Parkinson's disease: a 6-month open-label study.CNS Drugs. 2008;22(6):519-27. doi: 10.2165/00023210-200822060-00005. CNS Drugs. 2008. PMID: 18484793 Clinical Trial.
-
Minority enrollment in Parkinson's disease clinical trials.Parkinsonism Relat Disord. 2009 May;15(4):258-62. doi: 10.1016/j.parkreldis.2008.06.005. Epub 2008 Aug 9. Parkinsonism Relat Disord. 2009. PMID: 18693062 Free PMC article.
-
Current status of symptomatic medical therapy in Parkinson's disease.Neurotherapeutics. 2008 Apr;5(2):164-80. doi: 10.1016/j.nurt.2007.12.001. Neurotherapeutics. 2008. PMID: 18394561 Free PMC article. Review.
-
Role of apomorphine in the treatment of Parkinson's disease.CNS Drugs. 2015 Feb;29(2):83-9. doi: 10.1007/s40263-014-0221-z. CNS Drugs. 2015. PMID: 25676564 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
